Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tonix Pharm Hld (TNXP)

Tonix Pharm Hld (TNXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 221,378
  • Shares Outstanding, K 357,522
  • Annual Sales, $ 0 K
  • Annual Income, $ -50,460 K
  • 60-Month Beta 1.32
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.29
Trade TNXP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.33
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/09/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6000 +3.20%
on 09/16/21
0.7778 -20.39%
on 08/24/21
-0.0493 (-7.37%)
since 08/17/21
3-Month
0.6000 +3.20%
on 09/16/21
1.2900 -52.00%
on 06/28/21
-0.6008 (-49.25%)
since 06/17/21
52-Week
0.5100 +21.41%
on 11/10/20
2.1200 -70.79%
on 02/11/21
-0.3708 (-37.45%)
since 09/17/20

Most Recent Stories

More News
Tonix Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of...

TNXP : 0.6192 (-1.79%)
California and NYC Order Mandatory COVID-19 Testing Among Municipal Workers

/PRNewswire/ -- New COVID-19 cases continue to surge throughout , causing municipal governments to spring into action to combat the rising number of the highly infectious Delta variant cases. On Monday,...

TNXP : 0.6192 (-1.79%)
VXRT : 8.41 (+2.31%)
COCP : 1.0500 (-2.78%)
ALT : 15.24 (-7.07%)
SIXW.CN : 0.315 (-3.08%)
SIXWF : 0.2465 (-6.27%)
Tonix Pharmaceuticals Announces Groundbreaking Ceremony for Massachusetts R&D Facility to House the Advanced Development Center (ADC) for Vaccine Programs

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced it will hold a groundbreaking ceremony at the Company's planned 45,000...

TNXP : 0.6192 (-1.79%)
Tonix Pharmaceuticals Announces New Board Member, Carolyn E. Taylor

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix), a clinical-stage biopharmaceutical company, today announced the appointment of Carolyn E. Taylor to its Board of Directors, effective as of July...

TNXP : 0.6192 (-1.79%)
Tonix Pharmaceuticals Added to Russell 2000(R) and Russell 3000(R) Indexes

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Tonix was added to the broad-market Russell 3000 index and the...

TNXP : 0.6192 (-1.79%)
Thinking about buying stock in Pieris Pharmaceuticals, Paysafe, Tonix Pharmaceuticals, FibroGen, or Arbutus Biopharma?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PIRS, PSFE, TNXP, FGEN, and ABUS.

ABUS : 4.35 (+0.93%)
FGEN : 11.69 (-0.26%)
TNXP : 0.6192 (-1.79%)
PIRS : 5.85 (+1.56%)
PSFE : 8.18 (-0.85%)
Tonix Pharmaceuticals to Present at Raymond James Human Health Innovation Conference

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of...

TNXP : 0.6192 (-1.79%)
Tonix Pharmaceuticals to Participate in BIO Digital Conference

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of...

TNXP : 0.6192 (-1.79%)
Thinking about buying stock in BlackBerry, Solid Biosciences, Salem Media, Tonix Pharmaceuticals, or Palantir?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BB, SLDB, SALM, TNXP, and PLTR.

SLDB : 2.80 (+4.87%)
SALM : 3.00 (+4.90%)
TNXP : 0.6192 (-1.79%)
BB : 10.03 (-1.28%)
PLTR : 28.71 (+0.28%)
Tonix Pharmaceuticals Presents Positive Results from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the poster presentation of positive results from its Phase 3 clinical...

TNXP : 0.6192 (-1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102,...

See More

Key Turning Points

3rd Resistance Point 0.6576
2nd Resistance Point 0.6463
1st Resistance Point 0.6327
Last Price 0.6192
1st Support Level 0.6078
2nd Support Level 0.5965
3rd Support Level 0.5829

See More

52-Week High 2.1200
Fibonacci 61.8% 1.5050
Fibonacci 50% 1.3150
Fibonacci 38.2% 1.1250
Last Price 0.6192
52-Week Low 0.5100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar